HIV-1 viral decay in blood and semen in antiretroviral-naive adults initiating dolutegravir/lamivudine versus bictegravir/emtricitabine/tenofovir alafenamide

被引：0
|
作者：
Wang, Ran [1 ]
Liu, Yongjian [2 ]
Sun, Lijun [1 ]
Li, Aixin [1 ]
Lv, Shiyun [1 ]
Zhai, Yuanyi [1 ]
Li, Rui [1 ]
Hua, Wei [1 ]
Wang, Xi [1 ]
Li, Lin [2 ]
Dai, Lilli [1 ]
机构：
[1] Capital Med Univ, Beijing Youan Hosp, Ctr Infect Dis, Beijing, Peoples R China
[2] Acad Mil Med Sci, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2024年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P114
引用
收藏
页码：121 / 121
页数：1
相关论文
共 50 条
  • [31] Bictegravir/emtricitabine/tenofovir alafenamide in adults with HIV-1 and end-stage kidney disease on chronic haemodialysis
    Eron, Joseph J.
    Ramgopal, Moti
    Osiyemi, Olayemi
    Mckellar, Mehri
    Slim, Jihad
    Dejesus, Edwin
    Arora, Priyanka
    Blair, Christiana
    Hindman, Jason T.
    Wilkin, Aimee
    HIV MEDICINE, 2025, 26 (02) : 302 - 307
  • [32] Decay kinetics of HIV-1-RNA in seminal plasma with dolutegravir/lamivudine versus dolutegravir plus emtricitabine/tenofovir alafenamide in treatment-naive people living with HIV ( vol 78 , pg 2354 , 2023)
    Saborido-Alconchel, Abraham
    Serna-Gallego, Ana
    Lopez-Cortes, Luis E.
    Trujillo-Rodriguez, Maria
    Praena-Fernandez, Juan Manuel
    Dominguez-Macias, Montserrat
    Lozano, Carmen
    Munoz-Muela, Esperanza
    Espinosa, Nuria
    Roca-Oporto, Cristina
    Sotomayor, Cesar
    Herrero, Marta
    Gutierrez-Valencia, Alicia
    Lopez-Cortes, Luis F.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (01) : 205 - 205
  • [33] Efficacy of bictegravir/emtricitabine/tenofovir alafenamide versus dolutegravir-based three-drug regimens in people with HIV with varying adherence to antiretroviral therapy
    Andreatta, Kristen
    Sax, Paul E.
    Wohl, David
    D'Antoni, Michelle L.
    Liu, Hui
    Hindman, Jason T.
    Callebaut, Christian
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024,
  • [34] Comparison of dolutegravir plus Lamivudine and bictegravir/emtricitabine/tenofovir alafenamide in antiretroviral therapy-naïve patients infected with HIV: preliminary results from clinical practice
    Gan, Lin
    Xie, Xiaoxin
    Fu, Yanhua
    Yang, Xiaoyan
    Ma, Shujing
    Kong, Linghong
    Song, Chunli
    Song, Yebing
    Ren, Tingting
    Long, Hai
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2024, 22 (10) : 877 - 884
  • [35] Cost-efectiveness analysis of emtricitabine/tenofovir versus lamivudine/zidovudine, in combination with efavirenz, in antiretroviral-naive, HIV-1-Infected patients
    Sanchez-de la Rosa, Rainel
    Herrera, Luis
    Moreno, Santiago
    CLINICAL THERAPEUTICS, 2008, 30 (02) : 372 - 381
  • [36] Real-world persistence with dolutegravir/lamivudine versus bictegravir/ emtricitabina/tenofovir-alafenamide among people with HIV
    Martin-Zaragoza, Lorena
    Sanchez-Rubio-Ferrandez, Javier
    Onteniente-Gonzalez, Alberto
    Gomez-Bermejo, Marcos
    Rodriguez-Alvarez, Sergio Julio
    Monereo-Alonso, Alfonso
    Molina-Garcia, Teresa
    FARMACIA HOSPITALARIA, 2024, 48 (04) : 171 - 175
  • [37] Resistance Analysis of Bictegravir-Emtricitabine-Tenofovir Alafenamide in HIV-1 Treatment-Naive Patients through 48 Weeks
    Acosta, Rima K.
    Willkom, Madeleine
    Martin, Ross
    Chang, Silvia
    Wei, Xuelian
    Garner, William
    Lutz, Justin
    Majeed, Sophia
    SenGupta, Devi
    Martin, Hal
    Quirk, Erin
    White, Kirsten L.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (05)
  • [38] Efficacy of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) versus dolutegravir combinations in HIV-1 adult population: A systematic review and meta-analysis
    Biju, Anto Amith J.
    Shaju, Aina
    Mudigubba, Manoj Kumar
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 325 - 326
  • [39] Higher Risk of Dyslipidemia With Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide than Efavirenz, Lamivudine, and Tenofovir Disoproxil Fumarate Among Antiretroviral-Naive People Living With HIV in China
    Sun, Liqin
    He, Yun
    Xu, Liumei
    Zhao, Fang
    Zhou, Yang
    Zhang, Lukun
    Peng, Qiaoli
    Zhang, Haitao
    Zhang, Qiuyue
    Cao, Tingzhi
    Song, Ying
    Wang, Siyuan
    Rao, Man
    Jia, Xinyun
    Liu, Xiaoning
    Zhou, Jing
    Ju, Bin
    Wang, Hui
    Liu, Jiaye
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2022, 91 : S8 - S15
  • [40] Nevirapine versus atazanavir/ritonavir, each combined with tenofovir disoproxil fumarate/emtricitabine, in antiretroviral-naive HIV-1 patients: the ARTEN Trial
    Soriano, Vicente
    Arasteh, Keikawus
    Migrone, Horacio
    Lutz, Thomas
    Opravil, Milos
    Andrade-Villanueva, Jaime
    Antunes, Francisco
    Di Perri, Giovanni
    Podzamczer, Daniel
    Taylor, Steve
    Domingo, Pere
    Gellermann, Holger
    de Rossi, Lothar
    ANTIVIRAL THERAPY, 2011, 16 (03) : 339 - 348
12345